GL1X · GenesisL1 explorer

Research workbench

Pyrrolopyrimidine inhibitors of DNA gyrase B and topoisomerase IV, part I: structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity.

Analyse Pyrrolopyrimidine inhibitors of DNA gyrase B and topoisomerase IV, part I… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4HYM
Type
protein
Length
587 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Topoisomerase IV, subunit B
EC
5.99.1.3
UniProt
Q2A1P5
Ligands
CJC
Pockets
5 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATopoisomerase IV, subunit B (EC 5.99.1.3)protein36133% helix, 31% strandQ2A1P5
BTopoisomerase IV, subunit B (EC 5.99.1.3)protein22626% helix, 31% strandQ2A1P5

Ligands and binding sites

  • CJC · 7-({4-[(3R)-3-aminopyrrolidin-1-yl]-5-chloro-6-ethyl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}sulfanyl)pyrido[2,3-b]pyrazin-2(1H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18890.670.7477empty
25180.650.7751CJC
3600.380.8018empty
4970.380.7621empty
5730.340.7618empty

Interfaces

1 interface between chains.

  • A–B · 322 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 4HYM · Pyrrolopyrimidine inhibitors of dna gyrase b and topoisomerase iv, part i: structure… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.